Hoogeveen, R. M., Verweij, S. L., Kaiser, Y., Kroon, J., Verberne, H. J., Vogt, L., . . . Stroes, E. S. G. (2021). Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease. Nature Portfolio.
Style de citation Chicago (17e éd.)Hoogeveen, Renate M., Simone L. Verweij, Yannick Kaiser, Jeffrey Kroon, Hein J. Verberne, Liffert Vogt, Sophie J. Bernelot Moens, et Erik S. G. Stroes. Atorvastatin Treatment Does Not Abolish Inflammatory Mediated Cardiovascular Risk in Subjects with Chronic Kidney Disease. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Hoogeveen, Renate M., et al. Atorvastatin Treatment Does Not Abolish Inflammatory Mediated Cardiovascular Risk in Subjects with Chronic Kidney Disease. Nature Portfolio, 2021.